INTECH Investment Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
INTECH Investment Management's IRMD Position: Q2 2026 in Review
INTECH Investment Management increased its iRadimed (IRMD) stake by 12% in Q2 2026, buying an estimated $25.9K and bringing the position to 2,687 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.
INTECH Investment Management first reported a position in IRMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $304K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- INTECH Investment Management held 2,687 shares of iRadimed worth $257K as of Q2 2026.
- INTECH Investment Management bought 284 iRadimed shares in Q2 2026, an estimated $25.9K.
- iRadimed made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1663 holding.
- INTECH Investment Management first reported a position in iRadimed in Q1 2025 and has held it in 6 quarters since.
- INTECH Investment Management's iRadimed position peaked at $304K in Q4 2025.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.